Antidepressant-Induced Sleep Bruxism: Prevalence, Incidence, and Related Factors

Basit Öğe Kaydı
dc.contributor.authorUca, Ali Ulvi
dc.contributor.authorUguz, Faruk
dc.contributor.authorKozak, Hasan Huseyin
dc.contributor.authorGumus, Haluk
dc.contributor.authorAksoy, Fadime
dc.contributor.authorSeyithanoglu, Abdullah
dc.contributor.authorKurt, Hatice Guncu
dc.date.accessioned2024-02-23T14:23:32Z
dc.date.available2024-02-23T14:23:32Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractObjective The relationship between sleep bruxism and antidepressant drugs in patients remains unclear. In this study, we aimed to investigate the incidence rate of antidepressant-related bruxism and to examine whether antidepressant use is associated with this adverse effect in the patients. Methods The study sample was gathered from 2 hospitals. A total of 807 patients who met the inclusion criteria were included in the study. The sample was divided into 2 groups: the antidepressant group (n = 506) and the control group (n = 301). Sleep bruxism was established with reports from the study participants on the basis of the International Classification of Sleep Disorders: Diagnosis and Coding Manual Second Edition. Results The prevalence of bruxism was significantly higher in the antidepressant group (24.3%) than in the control group (15.3%). The incidence of antidepressant-induced bruxism was 14.0%. The antidepressants most associated with bruxism were paroxetine, venlafaxine, and duloxetine. The patients experiencing antidepressant-induced bruxism had higher age compared with those who did not experience this adverse effect. Conclusions The results of the present study suggest that bruxism is frequently observed in women taking antidepressants and that it seems to be associated with antidepressant use at least in some patients.en_US
dc.identifier.doi10.1097/WNF.0000000000000108
dc.identifier.endpage230en_US
dc.identifier.issn0362-5664
dc.identifier.issn1537-162X
dc.identifier.issue6en_US
dc.identifier.pmid26536018en_US
dc.identifier.scopus2-s2.0-84947867713en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage227en_US
dc.identifier.urihttps://doi.org/10.1097/WNF.0000000000000108
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13596
dc.identifier.volume38en_US
dc.identifier.wosWOS:000365616200002en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofClinical Neuropharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntidepressanten_US
dc.subjectSleep Bruxismen_US
dc.subjectPrevalenceen_US
dc.subjectIncidenceen_US
dc.titleAntidepressant-Induced Sleep Bruxism: Prevalence, Incidence, and Related Factorsen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu